Hormonal Antineoplastic Agents

Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079)
Also Known As:
Antineoplastic Agents, Hormonal; Antineoplastic Drugs, Hormonal; Antineoplastic Hormonal Agents; Antineoplastic Hormonal Drugs; Antineoplastics, Hormonal; Hormonal Agents, Antineoplastic; Hormonal Antineoplastic Drugs; Hormonal Antineoplastics; Agents, Antineoplastic Hormonal; Drugs, Antineoplastic Hormonal; Hormonal Drugs, Antineoplastic
Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results


1. Grabowsky, Jennifer A: 1 article (07/2013)

Related Diseases

1. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. everolimus